Clinical Trial Update: Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating adjuvant androgen suppression combined with radiation therapy for high-risk localized prostate cancer; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dr. Tamim Niazi | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: COMPLETED